
Sign up to save your podcasts
Or
Introducing Weight Loss and GLP-1 Meds with Dr. Ania Jastreboff from The Oprah Podcast.
Follow the show: The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.
Also referenced in this episode: "The Let Them Theory: A Life-Changing Tool That Millions of People Can’t Stop Talking About" by Mel Robbins, published by Hay House LLC is available wherever books and audio books are sold.
SUPPORT THE SHOW
Subscribe: https://www.youtube.com/@Oprah
Find Oprah’s Interview with Mel Robbins Here.
Follow Amy on Instagram
Follow Amy on TikTok
Follow Emma on TikTok
Follow Emma on Instagram
Follow Oprah Winfrey on Social:
Learn more about your ad choices. Visit megaphone.fm/adchoices
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
4.7
542542 ratings
Introducing Weight Loss and GLP-1 Meds with Dr. Ania Jastreboff from The Oprah Podcast.
Follow the show: The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.
Also referenced in this episode: "The Let Them Theory: A Life-Changing Tool That Millions of People Can’t Stop Talking About" by Mel Robbins, published by Hay House LLC is available wherever books and audio books are sold.
SUPPORT THE SHOW
Subscribe: https://www.youtube.com/@Oprah
Find Oprah’s Interview with Mel Robbins Here.
Follow Amy on Instagram
Follow Amy on TikTok
Follow Emma on TikTok
Follow Emma on Instagram
Follow Oprah Winfrey on Social:
Learn more about your ad choices. Visit megaphone.fm/adchoices
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
6,582 Listeners
27,018 Listeners
15,752 Listeners
5,136 Listeners
7,084 Listeners
2,199 Listeners
4,307 Listeners
2,473 Listeners
1,102 Listeners
557 Listeners
1,836 Listeners
1,801 Listeners
1,313 Listeners
1,984 Listeners
752 Listeners
768 Listeners
403 Listeners
574 Listeners
820 Listeners
105 Listeners
505 Listeners
279 Listeners
579 Listeners
298 Listeners
31 Listeners
460 Listeners
353 Listeners
230 Listeners
14 Listeners
120 Listeners
125 Listeners